Skip to main content
Premium Trial:

Request an Annual Quote

Stilla Technologies Raises €31.3M in Financing

NEW YORK – Stilla Technologies announced on Tuesday it has raised €31.3 million ($35.2 million) in new funding. The Paris-based firm will use the funds to expand its global commercial presence and develop its next-generation digital PCR platform.

The funding is in the form of €11.3 million of convertible bonds and €20 million in loan financing.

It includes new funding from existing investors Illumina Ventures, Kurma Partners, TusPark Capital Management, LBO France, BNP Paribas Developpement, and Eurazeo. New investment also comes from life science firm Casdin Capital and the European Investment Bank.

"This latest financing will enable us to continue to support our commercial growth in the North American and European markets and our strategic distribution networks in Asia, as well as sustain our pace of product innovation as we look to our next phase,” said Philippe Mourere, president and CEO of Stilla Technologies.

Stilla recently launched the six-color Naica system, which the firm says is the industry's highest multiplexing digital PCR system.

Nick Naclerio, founding partner at Illumina Ventures, said the team sees "incredible promise" in Stilla's platform to "accelerate the utilization of genomics data in routine translational research and clinical settings."

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.